{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:28:19Z","timestamp":1790018899687,"version":"4.0.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ymgme.2012.10.011","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T08:18:53Z","timestamp":1350548333000},"page":"748-755","source":"Crossref","is-referenced-by-count":48,"title":["Oral monosaccharide therapies to reverse renal and muscle hyposialylation in a mouse model of GNE myopathy"],"prefix":"10.1016","volume":"107","author":[{"given":"Terren K.","family":"Niethamer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Yardeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petcharat","family":"Leoyklang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Astiz-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi M.","family":"Dorward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Zerfas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Huizing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.10.011_bb0005","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbadis.2009.07.001","article-title":"Hereditary inclusion body myopathy: a decade of progress","volume":"1792","author":"Huizing","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2012.10.011_bb0010","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.nurt.2008.07.004","article-title":"The hereditary inclusion body myopathy enigma and its future therapy","volume":"5","author":"Argov","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ymgme.2012.10.011_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1152\/physiolgenomics.90219.2008","article-title":"Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV\/hIBM","volume":"35","author":"Malicdan","year":"2008","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ymgme.2012.10.011_bb0020","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00002281-199811000-00005","article-title":"Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis","volume":"10","author":"Askanas","year":"1998","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0025","doi-asserted-by":"crossref","first-page":"24313","DOI":"10.1074\/jbc.272.39.24313","article-title":"A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase","volume":"272","author":"Hinderlich","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ng718","article-title":"The UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy","volume":"29","author":"Eisenberg","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/humu.9100","article-title":"Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps","volume":"21","author":"Eisenberg","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0040","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/01.WNL.0000041631.28557.C6","article-title":"Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy","volume":"59","author":"Nishino","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.10.011_bb0045","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1096\/fasebj.11.4.9068613","article-title":"Sialic acids as ligands in recognition phenomena","volume":"11","author":"Varki","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0245","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.sbi.2009.06.003","article-title":"Sialic acids as regulators of molecular and cellular interactions","volume":"19","author":"Schauer","year":"2009","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0055","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.284.5418.1372","article-title":"UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation","volume":"284","author":"Keppler","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2012.10.011_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.molmed.2008.06.002","article-title":"Sialic acids in human health and disease","volume":"14","author":"Varki","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0065","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/glycob\/cwi100","article-title":"Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy","volume":"15","author":"Sparks","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2012.10.011_bb0070","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ymgme.2003.11.012","article-title":"Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations","volume":"81","author":"Huizing","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0075","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1074\/jbc.M313171200","article-title":"Reduction of UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles","volume":"279","author":"Noguchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0080","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9440(10)62332-2","article-title":"Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins","volume":"166","author":"Tajima","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0085","doi-asserted-by":"crossref","first-page":"e10055","DOI":"10.1371\/journal.pone.0010055","article-title":"Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease","volume":"5","author":"Paccalet","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2012.10.011_bb0090","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1212\/01.wnl.0000200956.76449.3f","article-title":"NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations","volume":"66","author":"Ricci","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.10.011_bb0095","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1073\/pnas.072066199","article-title":"Sialylation is essential for early development in mice","volume":"99","author":"Schwarzkopf","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0100","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI30954","article-title":"Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine","volume":"117","author":"Galeano","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0105","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ajpath.2011.12.023","article-title":"The Gne M712T mouse as a model for human glomerulopathy","volume":"180","author":"Kakani","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0110","doi-asserted-by":"crossref","first-page":"15708","DOI":"10.1074\/jbc.272.25.15708","article-title":"Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin","volume":"272","author":"Kershaw","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0115","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.1073\/pnas.95.20.11751","article-title":"A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence","volume":"95","author":"Chou","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1515\/BC.2001.036","article-title":"Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase","volume":"382","author":"Hinderlich","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0125","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jgm.1450","article-title":"Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy","volume":"12","author":"Nemunaitis","year":"2010","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0130","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1089\/hum.2010.192","article-title":"Hereditary inclusion body myopathy: single patient response to intravenous dosing of GNE gene lipoplex","volume":"22","author":"Nemunaitis","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1020884312053","article-title":"Food intake, water intake, and drinking spout side preference of 28 mouse strains","volume":"32","author":"Bachmanov","year":"2002","journal-title":"Behav. Genet."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ab.2008.12.005","article-title":"Specificity analysis of lectins and antibodies using remodeled glycoproteins","volume":"386","author":"Iskratsch","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0145","doi-asserted-by":"crossref","first-page":"20171","DOI":"10.1074\/jbc.M603452200","article-title":"Biochemical and structural analysis of Helix pomatia agglutinin. A hexameric lectin with a novel fold","volume":"281","author":"Sanchez","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0014-5793(92)80937-C","article-title":"Carbohydrate binding specificity of the Tn-antigen binding lectin from Vicia villosa seeds (VVLB4)","volume":"312","author":"Puri","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0155","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0021-9258(19)75677-4","article-title":"The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2\u20136)Gal\/GalNAc sequence","volume":"262","author":"Shibuya","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0160","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2004.12.157","article-title":"No overall hyposialylation in hereditary inclusion body myopathy myoblasts carrying the homozygous M712T GNE mutation","volume":"328","author":"Salama","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0165","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ymgme.2006.04.011","article-title":"Normal sialylation of serum N-linked and O-GalNAc-linked glycans in hereditary inclusion-body myopathy","volume":"88","author":"Savelkoul","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0170","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1471-4159.2007.05208.x","article-title":"Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle","volume":"105","author":"Broccolini","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0175","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1172\/JCI32482","article-title":"Sizing up sialic acid in glomerular disease","volume":"117","author":"Quaggin","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0180","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/hmg\/ddm220","article-title":"A Gne knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy","volume":"16","author":"Malicdan","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0185","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nm.1956","article-title":"Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model","volume":"15","author":"Malicdan","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0190","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1172\/JCI2350","article-title":"Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy","volume":"101","author":"Niehues","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0195","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1651-2227.2002.tb00101.x","article-title":"Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency","volume":"91","author":"Harms","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rdc.2010.11.007","article-title":"Glucosamine and chondroitin sulfate","volume":"37","author":"Miller","year":"2011","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/ecp.09.17","article-title":"Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations","volume":"2","author":"Altman","year":"2009","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0210","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/ndt\/gfp278","article-title":"FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy","volume":"24","author":"De Smet","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0215","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1016\/S0021-9258(18)63041-8","article-title":"Metabolism of exogenous D-mannosamine","volume":"245","author":"Raisys","year":"1970","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0220","doi-asserted-by":"crossref","first-page":"53045","DOI":"10.1074\/jbc.M309967200","article-title":"Lec3 Chinese hamster ovary mutants lack UDP-N-acetylglucosamine 2-epimerase activity because of mutations in the epimerase domain of the Gne gene","volume":"278","author":"Hong","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10719-006-6484-y","article-title":"KDN (deaminated neuraminic acid): dreamful past and exciting future of the newest member of the sialic acid family","volume":"23","author":"Inoue","year":"2006","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0230","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.yexcr.2010.05.022","article-title":"Gene therapy for muscle disease","volume":"316","author":"Miyagoe-Suzuki","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712598.4.1.1","article-title":"Stem cell therapy for muscular dystrophy","volume":"4","author":"Sohn","year":"2004","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.ymgme.2012.10.011_bb0240","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1517\/14712598.2011.548800","article-title":"Intramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data","volume":"11","author":"Skuk","year":"2011","journal-title":"Expert Opin. Biol. Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212003794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719212003794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T10:17:35Z","timestamp":1643537855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719212003794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1096719212003794"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.10.011","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}